Levodopa and carbidopa SC solution

( DrugBank: Levodopa / KEGG DRUG: Levodopa )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	3

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04006210 (ClinicalTrials.gov)	August 27, 2019	30/6/2019	Efficacy, Safety andTolerability Study of ND0612 vs. Oral IR-LD/CD in Subjects With PD Experiencing ...	A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Study of th ...	Parkinson's Disease	Combination Product: ND0612 Solutionfor SCinfusion;Combination Product: Placebo for SCinfusion;Drug: ...	NeuroDerm Ltd.	NULL	Active, not recruiting	30 Years	80 Years	All	381	Phase 3	United States;Austria;Belgium;Czechia;France;Hungary;Israel;Italy;Netherlands;Poland;Portugal;Russia ...
2	NCT02096601 (ClinicalTrials.gov)	August 2014	18/3/2014	A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Pati ...	A Phase I/II Pharmacokinetic (PK) Study of ND0612, a Liquid Formulation of Levodopa/Carbidopa(LD/CD) ...	Parkinson's Disease	Drug: Levodopa and carbidopa SC solution;Drug: Oral levodopa and carbidopa	NeuroDerm Ltd.	Michael J. Fox Foundation for Parkinson's Research	Completed	30 Years	80 Years	All	16	Phase 1/Phase 2	United States;Israel
3	NCT01725802 (ClinicalTrials.gov)	December 2012	4/11/2012	A Phase I/IIa Study of Safety, Tolerability andPlasma Concentration of Subcutaneous Continuously-del ...	A Phase I/IIa, Single Dose, Single-centre, Randomized, Crossover, Double-blind, Placebo-controlled S ...	Parkinson's Disease	Drug: levodopa and carbidopa solution for SC administration;Drug: Placebo	NeuroDerm Ltd.	NULL	Completed	30 Years	N/A	Both	8	Phase 1/Phase 2	Israel

First Previous1Next Last